Paul Tudor Jones Elevance Health, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Elevance Health, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 41,178 shares of ELV stock, worth $15.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

41,178

Previous 900 4475.33%

Holding current value

$15.1 Million

Previous $487,000 4296.71%

% of portfolio

0.08%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$500.12 - $562.29 $20.6 Million - $23.2 Million	41,178 New	41,178 $21.4 Million
Q3 2023 Nov 15, 2023	SELL	$414.13 - $475.93 $5.13 Million - $5.89 Million	-12,376 Reduced 80.52%	2,994 $1.3 Million
Q2 2023 Aug 14, 2023	BUY	$436.33 - $496.2 $4.96 Million - $5.64 Million	11,368 Added 284.06%	15,370 $6.83 Million
Q1 2023 May 15, 2023	BUY	$446.3 - $502.2 $1.79 Million - $2.01 Million	4,002 New	4,002 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$445.98 - $507.0 $6.03 Million - $6.85 Million	13,515 Added 48.52%	41,368 $18.8 Million
Q2 2022 Aug 15, 2022	BUY	$444.32 - $529.84 $10.8 Million - $12.9 Million	24,356 Added 696.48%	27,853 $13.4 Million
Q1 2022 May 16, 2022	BUY	$428.44 - $502.48 $98,112 - $115,067	229 Added 7.01%	3,497 $1.72 Million
Q3 2021 Nov 15, 2021	SELL	$357.51 - $398.13 $2.71 Million - $3.02 Million	-7,584 Reduced 69.89%	3,268 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$352.19 - $401.9 $3.82 Million - $4.36 Million	10,852 New	10,852 $4.14 Million
Q1 2021 May 17, 2021	SELL	$287.7 - $371.31 $1.89 Million - $2.45 Million	-6,586 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$270.17 - $333.15 $1.65 Million - $2.04 Million	-6,109 Reduced 48.12%	6,586 $2.12 Million
Q3 2020 Nov 16, 2020	SELL	$245.73 - $284.63 $461,480 - $534,535	-1,878 Reduced 12.89%	12,695 $3.41 Million
Q2 2020 Aug 14, 2020	BUY	$203.3 - $300.59 $1.15 Million - $1.7 Million	5,659 Added 63.48%	14,573 $3.83 Million
Q1 2020 May 15, 2020	SELL	$174.68 - $307.74 $875,146 - $1.54 Million	-5,010 Reduced 35.98%	8,914 $2.02 Million
Q4 2019 Feb 14, 2020	SELL	$234.82 - $306.42 $7.71 Million - $10.1 Million	-32,844 Reduced 70.23%	13,924 $4.21 Million
Q3 2019 Nov 14, 2019	BUY	$237.69 - $310.48 $11.1 Million - $14.5 Million	46,768 New	46,768 $11.2 Million
Q2 2019 Aug 14, 2019	SELL	$236.25 - $293.76 $2.16 Million - $2.69 Million	-9,151 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$248.42 - $317.42 $2.27 Million - $2.9 Million	9,151 New	9,151 $2.63 Million
Q1 2018 May 15, 2018	SELL	$215.63 - $258.19 $2.57 Million - $3.07 Million	-11,904 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$183.76 - $234.96 $140,943 - $180,214	767 Added 6.89%	11,904 $2.68 Million
Q3 2017 Nov 14, 2017	BUY	$181.44 - $197.43 $2.02 Million - $2.2 Million	11,137	11,137 $2.12 Million

Others Institutions Holding ELV

# of Institutions

1,861

Shares Held

197M

Call Options Held

1.03M

Put Options Held

1.24M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $88.1B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account